comparemela.com

Page 2 - Legacy Immunovant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pomerantz Law Firm Announces the Filing of a Class Action against Immunovant, Inc f/k/a Health Sciences Acquisitions Corporation and Certain Officers

Pomerantz Law Firm Announces the Filing of a Class Action against Immunovant, Inc f/k/a Health Sciences Acquisitions Corporation and Certain Officers
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

DEADLINE ALERT for BLUE, EH, JT, IMVT: Law Offices of Howard G Smith Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for IMVT, EBIX, APA, and MPLN: The Law Offices of Frank R Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for IMVT, EBIX, APA, and MPLN: The Law Offices of Frank R Cruz Reminds Investors of Class Actions on Behalf of Shareholders
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

DEADLINE ALERT for BLUE, EH, JT, IMVT: Law Offices of Howard G Smith Reminds Investors of

IMVT INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc

IMVT INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc. March 07, 2021 11:11 ET | Source: Bernstein Liebhard LLP Bernstein Liebhard LLP New York, New York, UNITED STATES NEW YORK, March 07, 2021 (GLOBE NEWSWIRE) Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Immunovant, Inc. (“Immunovant” or the “Company”) (NASDAQ: IMVT) from October 2, 2019 through February 1, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Eastern District of New York alleges violations of the Securities Exchange Act of 1934.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.